1 / 45

Hemodynamic Monitoring

Hemodynamic Monitoring. Khaled O. Hadeli 12/7/99. DO2 = CO x 13.4 x Hb x SaO2 DO2 = (SV x HR) 13.4 x Hb x SaO2. MR. RVF. Hypovolemic shock. Acute bronchospasm. Busy Tracing. Cardiac performance CO/CI CVP/RAP/RVP/PAP/ Pcwp RVEF SVR/PVR. O2 transport parameters

maureen-cashman
Download Presentation

Hemodynamic Monitoring

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hemodynamic Monitoring Khaled O. Hadeli 12/7/99

  2. DO2 = CO x 13.4 x Hb x SaO2 DO2 = (SV x HR) 13.4 x Hb x SaO2

  3. MR

  4. RVF

  5. Hypovolemic shock

  6. Acute bronchospasm

  7. Busy Tracing

  8. Cardiac performance CO/CI CVP/RAP/RVP/PAP/ Pcwp RVEF SVR/PVR O2 transport parameters DO2 SvO2 VO2 O2ER PAC

  9. Physiology of cardiac performance • Pre-Load • contractility: Frank-Starling Law, ( within physiologic limits the strength of muscle contraction is directly related to the length of the muscle fiber) • compliance

  10. After-Load • It is the opposing force that determines the force of muscle contraction needed to initiate muscle shortening • Laplace Law: T=Pr T=Pr/t

  11. After-Load cont. • SVR = MABP-CVP/CO • PVR = MPBP-LAP/CO

  12. CLINICAL APPLICATIONS THE WEDGE PRESSURE

  13. The wedge pressure • Pcwp • LAP • LVED • LVEDV • Preload • SV--->CO

  14. Cardiac out put TEMP. TIME CO=Amount of indicator injected / Area under the curve

  15. DO2 = (SV x HR) 13.4 x HB x SaO2

  16. Complications • General • Delays in starting necessary treatment • Inaccurate measurements and false interpretations • Preoccupation with instrumentation

  17. Complications • Related to central venous cannulation • arterial puncture/hematoma 8% • pnemothorax 2-4% • others ( hemothorax, brachial plexus damage, air embolism, phrenic nerve damage, sheared cath…etc.) <1%

  18. Complications • Related to passage of catheter • Arrhythmia 13- 70% (1%) • RBBB • Cardiac perforation & tamponade (1%) • Over wedging leading to Pulmonary infarction (pt with severe MR)

  19. Related to presence of the cath. In circulation Infection colonization 40% sepsis 4-6% Thrombotic autopsy 66% clinical <1% Pulmonary infarction <1 - 7% artery rupture <1% Cardiac endocardial damage 35% valve damage <1% endocarditis 0 - 7% Mechanical Balloon rupture <4% knotting <1% Complications

  20. Limitation of Hemodynamic monitoring • Cost • Incorrect measurement of data • calibration, damping, zeroing • transient respiratory muscle activity • reliance on digital readout • failure to wedge • non zone-III region

  21. Cont. • Incorrect interpretation of data • ventricular compliance • valve disease • SCDs and false reading of CO • Improper therapeutic strategies - poor application of data on over zealous goals/targets

  22. Physician Knowledge of PAC PGY1 2-3 4-6 Staff Expert Iberti, JAMA 264:2928,1990

  23. Open Vs. Closed ICUs Significant improvement in mortality subsequent to the presence of CCM specialist in the ICU despite increased use of PAC Reynolds et. Al. JAMA1988:260;3446-50

  24. RHC vs.. NO RHC Connors, JAMA 276;889,1996

  25. Is it time to pull the PAC? • Moratorium on the use of PAC until a (RCT) provides more evidence* • ATS consensus statement against the moratorium, but use with caution untill (RCT) provides more evidence *Dalen et.al. JAMA 1996:276;916-8

  26. MEDIA • “…….1000$ procedure leads to increased mortality in our ICUs” • “…….are you safe if you stay in the ICU” • “ The pulmonary catheter cult”

  27. PAC use 1,000,000 RHC every year 2 Billion Dollars / year(1990)* • CT surgery 30% • high risk surgery 10% • cardiac cath. Lab 25% • MICU 15% • others20% *Shoemaker et al.

  28. Why do we need PAC • In cardiac cases (AMI) clinical criteria where predictive of pcwp and CO in 81% & 85% of the subjects, respectively • In ICU the estimates of pcwp & CO where 42%-44%. And another study 30%-50%. • In ICU the planned therapy was changed in 50% of patients after PAC was placed

  29. Potential impact on therapy • Hemodynamic profiles predicted in 56% • PAC derived profiles changed therapy in 50% • No change in over all mortality! • Improvement in mortality of Pts. With shock not responding to usual measures Mimoz et.al.CCM 1994;22:573-9

  30. PAC in ARDS • Optimize intervascular volume • Improved survival with high DO2* • Mean DO2 491ml/min/m2 in nonsurvivors • Mean DO2 718 ml/min/m2 in survivors • No benefit and some possible harm from non specific augmentation of DO2 in pts with ARDS** *Russell et a. **Gattinoni/Hayes, NEJM 1995/1994

  31. PAC, a diagnostic toll or a therapeutic modality?

  32. In the critically ill patient hemodynamic monitoring is aimed to optimize which of the following? a. CO/CI b. Pcwp c. BP d. DO2

  33. CASE A 65yr old male 4 days post-op developed sudden onset of fever, chills and SOB. Vitals show HR 130, BP 85/55 mmHg, RR40/min, PaO2 40mmHg. He was intubated and given 500cc NS, started on vasoactive therapy, and referred to MICU.

  34. Current hemodynamic data • BP 130/90 HR 120 • CO 11 l/min • SaO2 93% on 60% Fio2 • Urine out put 10cc/hr • Pcwp 12

  35. Your immediate action should be: A. give volume B. diurese C. leave volume status as is And / Or A. give more vasopressor therapy B. Taper vasopressor therapy C. leave vasoactive therapy as is

  36. Recommendations • PAC should be used when there is a question of diagnosis and management • Like all information it must be adequately processed • DON’T FORGET • what we measure is not always what we think it is • DO2 = SV x HR x 13.4 x Hb x SaO2

  37. A searchlight cannot be used effectively without a fairly thorough knowledge of the territory to be searched. Fergus Macartney, FRCP

More Related